Tafenoquine succinate for malaria, vivax

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Jul 2025: Trial registered, NCT07052162
  2. 20 Oct 2025: Trial started, NCT07052162

The trials

NCT07052162: Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children

State
Under way
Phase
Phase 4
People
30 planned
Started
20 Oct 2025
Primary completion
Mar 2026
Arms
Group A, Group B
Results
None posted
  1. 4 Jul 2025: Trial registered
  2. 20 Oct 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Arakoda, Krintafel, Single dose tafenoquine (10 mg/kg) given with fat, Single dose tafenoquine (10 mg/kg) given with water.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.